Navigation Links
Drug Development in Arizona Gets Boost Following ASU-Quintiles Agreement
Date:9/17/2010

PHOENIX, Sept. 17 /PRNewswire/ -- Arizona's contribution to the accelerated development of new, safe and effective medicines to help treat suffering patients in the US and around the world, will become greater following the signing of new deal between Arizona State University and Quintiles (www.quintiles.com), a global integrated biopharmaceutical services company which is a leader in managing clinical research.

The Center for Healthcare Innovation & Clinical Trials (https://nursingandhealth.asu.edu/clinical-trials).at ASU – part of the College of Nursing & Health Innovation – is only the fifth organization in the world to become a global prime site partner for Quintiles.

Through Quintiles the Center will receive access to many more clinical research initiatives. In return, the Center will deploy its unique community-based model to recruit more physicians and nurse practitioners who can identify patients who are willing and eligible to participate in the research.

Access to patients to participate in clinical trials is one of the major barriers to bringing much needed safe and effective drugs to market faster and with less cost.

Linda Mottle, Director of the Center for Healthcare Innovation & Clinical Trials at ASU, noted that the clinical research market in Arizona lags other states with comparable population sizes and explained: "We believe our community-based model can substantially increase the clinical research market in Arizona."

Adam Chasse, Senior Director for Patient Access at Quintiles, added: "Access to patients is one of the toughest hurdles in working with our biopharmaceutical customers to accelerate outcomes and get better value from the drug development process.  This agreement with ASU will help our customers to meet study milestones more effectively by providing access to large groups of physicians, known as 'investigators,' who are interested in participating in clinical research and who treat large groups of patients."

The ASU center is the only one of Quintiles' five global prime sites that is a community-based, non-academic medical center. ASU's model, the Community Oriented Network to Enhance Clinical Trials and Research (CONECTR), will serve as the hub for placing, subcontracting, consulting and supporting multi-phased research studies within Arizona.

Ken Levin, Chief Executive Officer of Precision Trials and a member of the Center Advisory Board, sees CONECTR providing multiple benefits for community research organizations:  "By offering assistance and support to providers, CONECTR will increase the number of qualified investigators and sites conducting research in Arizona. The program aligns clinical research pipeline opportunities with local investigators by their capability."

Quintiles' other prime site partners are Kaiser Permanente in Southern California, the University of Pretoria in South Africa, Queen Mary's College in London, Washington Hospital Center in Washington, D.C., and the University of Malaya in Malaysia.


'/>"/>
SOURCE Arizona State University College of Nursing & Health Innovation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DNASequencing.com and a Portfolio of 318 Genetic Domain Names to be Auctioned Off at Epik.com Domain Development Conference
2. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
3. Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
4. Zero Discharge Sweet Sorghum Ethanol Process Development
5. NASA funds development of nanoscale materials for high energy density lithium-ion batteries
6. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
7. Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview
8. Torbjorn Bjerke Appointed as new CEO for Karolinska Development
9. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
10. Clean Power Development, LLC Urges Sustainable, Community-Centric Approach to Biomass Energy
11. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... 2017 , ... Cambridge Semantics , a big data ... the Big Data special edition of CIOReview magazine. , Since 2013, CIOReview ... technologies and solutions that are advancing the industry and optimizing businesses. A distinguished ...
(Date:9/25/2017)... Portland, OR (PRWEB) , ... ... ... , an industry-leading Unified Communications (UC) and Collaboration company, and Bigleaf Networks, ... announced today a strategic alliance to extend CallTower’s Unified Communication applications with ...
(Date:9/22/2017)... ... September 22, 2017 , ... HOLLOWAY AMERICA, a stainless steel ... packaging event PACK EXPO International in Las Vegas from September 25 to 27. ... At this year’s PACK EXPO at the Last Vegas Convention Center, HOLLOWAY representatives ...
(Date:9/21/2017)... ... September 21, 2017 , ... Vixiar Medical ... engineering and manufacturing functions to The LaunchPort™ Accelerator at the City Garage in ... range of manufacturing and business services to its Residents. , Vixiar Medical ...
Breaking Biology Technology:
(Date:6/14/2017)... PARIS , June 15, 2017  IBM (NYSE: IBM ... the international tech event dedicated to developing collaboration between startups ... on June 15-17. During the event, nine startups will ... deliver value in various industries. ... in the international market, with a 30 percent increase in ...
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
Breaking Biology News(10 mins):